About PANOMEC

PANOMEC is a pharmaceutical product containing the active ingredient IVERMECTIN, a medication widely recognized for its efficacy in treating various parasitic infections. As a key player in the realm of anthelmintic drugs, PANOMEC is designed to combat infections caused by parasitic worms and other organisms. With its broad spectrum of activity, PANOMEC is an essential tool in the management of diseases such as onchocerciasis, lymphatic filariasis, and intestinal strongyloidiasis, among others.

Key Therapeutic Benefits

Effective against a wide range of parasitic infections, including those caused by nematodes and ectoparasites.
Highly potent in treating onchocerciasis, a disease caused by the parasitic worm Onchocerca volvulus, which can lead to river blindness.
Proven to be beneficial in the management of lymphatic filariasis, a condition that can cause severe swelling and disfigurement.

Active Ingredient Mechanism

IVERMECTIN, the active ingredient in PANOMEC, works by binding to glutamate-gated chloride channels in invertebrate nerve and muscle cells, causing hyperpolarization and subsequent paralysis of the parasites. This mechanism leads to the death of the parasites, thereby reducing the burden of infection and alleviating symptoms.

Important Medical Note:

PANOMEC should only be used under the guidance of a healthcare professional. It is crucial to follow the prescribed dosage and administration instructions carefully to ensure safe and effective treatment. Additionally, patients should be monitored for potential side effects and contraindications, especially in cases of pregnancy, breastfeeding, or known hypersensitivity to IVERMECTIN.